The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines

Brouwers, Melissa; Kho, Michelle E.; Browman, George P.; Burgers, Jako; Cluzeau, Françoise; Feder, Gene; Fervers, Béatrice; Graham, Ian D.; Grimshaw, Jeremy; Hanna, Steven; Littlejohns, Peter; Makarski, Julie; Zitzelsberger, Louise

doi:10.1016/j.jclinepi.2011.10.008

Cited by 92 publications

(73 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Second, only the AGREE-II instrument was used in evaluating the quality of the CPGs, nowadays the most comprehensive validated assessment tool. Although others instruments could be additionally employed 30 .…”

Section: Discussionmentioning

confidence: 99%

Therapeutic drug monitoring of benznidazole and nifurtimox: a systematic review and quality assessment of published clinical practice guidelines

Olivera

Fory

Olivera

2017

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

The pharmacological management of adults with chronic-phase Chagas disease is challenging despite it being the recent focus of extensive research. One of the challenges in the current clinical practice guidelines (CPGs) landscape is the existence of nonevidence-based recommendations for the use of laboratory tests in treatment monitoring. This study aimed to systematically assess the quality and consistency of recommendations of CPGs on the pharmacological management of adults with chronicphase Chagas disease. Systematic literature searches were conducted in MEDLINE, EMBASE, SciELO and Google to identify all published CPGs relevant to the pharmacological management of Chagas disease, between January 2010 and March 2016. Three independent reviewers assessed the quality of each CPG using the Appraisal of Guidelines Research and Evaluation (AGREE) II instrument. A total of fi ve CPGs were included and the overall quality of the guidelines for therapeutic drug monitoring of Chagas disease was moderate-to-low. There was considerable variation in the quality of the CPGs across the AGREE II domains. The domains of scope/purpose, stakeholder involvement, and clarity of presentation were rated well, and the domains of applicability and editorial independence received poor ratings. This review showed that the methodological quality of CPGs for Chagas disease was generally inappropriate, and there was no explicit link between the best available evidence and current recommendations.

show abstract

Section: Discussionmentioning

confidence: 99%

Therapeutic drug monitoring of benznidazole and nifurtimox: a systematic review and quality assessment of published clinical practice guidelines

Olivera

Fory

Olivera

2017

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

show abstract

“…Each CPG candidate was assessed by two Canadian Society for International Health experts for quality and applicability using AGREE II [4]. A four-item global rating scale was developed as alternative to AGREE II by the AGREE II authors, but it was the preference of our partners to use the full AGREE II tool [19]. We found the Web version of the AGREE II tool easy to use, and disagreement was resolved between the two experts before the assessment was finalized.…”

Section: 2mentioning

confidence: 99%

Clinical practice guidelines were adapted and implemented meeting country-specific requirements—the example of Kazakhstan

McGowan

Muratov

Tsepke

et al. 2016

Journal of Clinical Epidemiology

View full text Add to dashboard Cite

“…Additional tools such as AGREE (rigor of development domain) 32 or GRADE (strength of a recommendation) 33 could be used in conjunction with CATCH to assess scientific value of PEMs, while SMOG, Flesch Reading Ease, and FRY reading tests 34 could be used to assess readability.…”

Section: What Is New About Catch?mentioning

confidence: 99%

The Communication AssessmenT Checklist in Health (CATCH): A Tool for Assessing the Quality of Printed Educational Materials for Clinicians

Genova

Nahón-Serfaty

Gagnon

et al. 2014

Journal of Continuing Education in the Health Professions

View full text Add to dashboard Cite

show abstract

The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines

Cited by 92 publications

References 11 publications

Therapeutic drug monitoring of benznidazole and nifurtimox: a systematic review and quality assessment of published clinical practice guidelines

Therapeutic drug monitoring of benznidazole and nifurtimox: a systematic review and quality assessment of published clinical practice guidelines

Clinical practice guidelines were adapted and implemented meeting country-specific requirements—the example of Kazakhstan

The Communication AssessmenT Checklist in Health (CATCH): A Tool for Assessing the Quality of Printed Educational Materials for Clinicians

Contact Info

Product

Resources

About